Clinical Trials in Hubei, Wuhan
4 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 1
Preliminary Human Trials of F230 Tablets
Pulmonary Hypertension
Beijing Continent Pharmaceutical Co, Ltd.136 enrolled1 locationNCT06899815
Recruiting
Phase 1
A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
Renal Insufficiency, Chronic
Beijing Continent Pharmaceutical Co, Ltd.56 enrolled1 locationNCT07262333
Recruiting
Phase 2
The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma
Clinical IVb Stage Oral Squamous Cell Carcinomas Patients
Hospital of Stomatology, Wuhan University35 enrolled1 locationNCT06277791
Recruiting
Phase 1Phase 2
A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
Non-small Cell Lung Cancer
Allist Pharmaceuticals, Inc.104 enrolled21 locationsNCT05276726